Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Nakano; Hirofumi
Address:
Machida, JP
No. of patents:
17
Patents:












Patent Number Title Of Patent Date Issued
5925641 Farnesyltransferase inhibitor July 20, 1999
The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent lower alkyl, lower alkoxyalkyl, subst
5728830 Farnesyltransferase inhibitor March 17, 1998
The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent lower alkyl, lower alkoxyalkyl, subst
5717110 UCH15 compounds February 10, 1998
This invention relates to UCH15 compounds of the formula (I): ##STR1## wherein R.sup.1 represents a hydrogen atom or a hydroxyl group.
5686606 UCF116 compounds November 11, 1997
The present invention relates to UCF116 compounds represented by the formula (I) : ##STR1## wherein an example of Q.sup.1 representation is ##STR2## and an example of Q.sup.2 representation is ##STR3## which have antibacterial and antitumor activity and are useful as
5656736 Compound UCH9 August 12, 1997
The present invention relates to the compound UCH9 represented by the following formula: ##STR1## which has antibacterial and anti-tumor activity, and pharmaceutically acceptable salts thereof.
5565489 Epoxycyclohexenedione derivatives October 15, 1996
The present invention relates to an epoxycyclohexenedione derivative represented by formula (I): ##STR1## wherein R is a straight-chain or branched alkanoyl group having 10 to 25 carbon atoms, a straight-chain alkenoyl group having 10 to 25 carbon atoms, or a group represented by
5536850 Substance DC114-A1 July 16, 1996
The present invention relates to a novel substance DC114-A1 represented by the following formula (I): ##STR1##
5510501 Saintopin derivatives April 23, 1996
The present invention relates to Saintopin derivatives represented by the following formula (I): ##STR1## wherein R.sup.1 is hydrogen and R.sup.2 is SO.sub.2 OH (UCE 1022), or R.sup.1 is acetyl and R.sup.2 is H (Saintopin E), which are useful as antibacterial and anti-tumor agent
5079376 Novel substance UCT-1003 and process for producing the same January 7, 1992
Disclosed is novel compound UCT-1003 represented by the following formula: ##STR1## and having anti-tumor activity. UCT-1003 is produced by culturing a microorganism belonging to the genus Paecilomyces.
5066817 DC115A compounds produced by streptomyces sp. November 19, 1991
Disclosed are DC115A compounds represented by the following general formula: ##STR1## wherein R represents ethyl, propyl or 1-propenyl, and which have antibacterial and anti-tumor activity. DC115A compounds are produced by culturing a microorganism belonging to the genus Streptom
4999196 Compound DC-107 produced by Streptomyces sp. March 12, 1991
A novel compound, DC-107, is produced by culturing a microorganism belonging to the genus Streptomyces. It is useful as a medicine because of its antibacterial and anti-tumor activity.
4992570 UCN-1028A and UCN-1028C and process for the production thereof February 12, 1991
UCN-1028A and UCN-1028C having an anti-tumor activity and a protein kinase C inhibitory activity are produced by culturing a microorganism belonging to the genus Cladosporium.
4935415 UCN-01 and process for production thereof June 19, 1990
UCN-01 having an anti-tumor activity and an anti-bacterial activity is produced by culturing a microorganism belonging to the genus Streptomyces.
4914198 Novel substance UCY1003 and process for preparing the same April 3, 1990
Novel substance UCY1003 produced by culturing of a microorganism has the following chemical structure and analgesic, hypotensive and antifungal activities: ##STR1##
4847387 Antibiotic compounds DC-92B and DC-92D July 11, 1989
The present invention relates to novel compounds DC-92B and DC-92D having anthraquinone moiety and represented by the following planar structural formula (I) and to a process for producing the same. These compounds can be produced by culture of a microorganism belonging to the genus
4438197 Compound DC-38-V and process for production thereof March 20, 1984
The antibacterial compound DC-38-V is produced by culturing a microorganism belonging to the genus Streptomyces.
4340725 Novel compound DC-38-V and process for production thereof July 20, 1982
The antibacterial compound DC-38-V is produced by culturing a microorganism belonging to the genus Streptomyces.










 
 
  Recently Added Patents
Secure data exchange between data processing systems
Clusterin antisense therapy for treatment of cancer
Aisle barrier
Switching device, switch control method, and storage system
Domestic soda-water preparing device
Audiovisual multi-room support
DRAM refresh method and system
  Randomly Featured Patents
Carboxyalkylacylamino acids
Tent
Friction hinge with retention finger
Air delivery device
Image processing apparatus and method
Hand-held vacuum cleaner appliance
Electrophysiology catheter and remote actuator therefor
Lubricating oil for refrigerator
Providing relevance- and diversity-influenced advertisements including filtering
Method of screening for a carnitine transporter agonist or antagonist and its uses